Michel Branger

683 total citations
23 papers, 397 citations indexed

About

Michel Branger is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Michel Branger has authored 23 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 14 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in Michel Branger's work include Hepatitis C virus research (16 papers), Hepatitis B Virus Studies (14 papers) and Liver Disease Diagnosis and Treatment (7 papers). Michel Branger is often cited by papers focused on Hepatitis C virus research (16 papers), Hepatitis B Virus Studies (14 papers) and Liver Disease Diagnosis and Treatment (7 papers). Michel Branger collaborates with scholars based in France, Gabon and United Kingdom. Michel Branger's co-authors include Serge Erlinger, Patrick Marcellin, Jean‐François Korobelnik, T. Hoang–Xuan, D Hannouche, Jean-Eric Guez, Françoise Brun‐Vézinet, Michelle Martinot-Peignoux, Michèle Martinot‐Peignoux and J.P. Benhamou and has published in prestigious journals such as PLoS ONE, Gut and The Journal of Infectious Diseases.

In The Last Decade

Michel Branger

22 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Branger France 12 234 219 86 72 65 23 397
Andrzej Gładysz Poland 8 89 0.4× 145 0.7× 12 0.1× 9 0.1× 249 3.8× 42 472
Charles H. Sherwood United States 7 24 0.1× 214 1.0× 14 0.2× 109 1.5× 63 1.0× 8 323
Jin Cao China 8 21 0.1× 58 0.3× 45 0.5× 71 1.0× 19 0.3× 15 267
Jennifer Hoffmann United States 11 45 0.2× 165 0.8× 8 0.1× 16 0.2× 163 2.5× 15 313
Corklin Steinhart United States 10 74 0.3× 141 0.6× 8 0.1× 9 0.1× 391 6.0× 21 566
Enzo Raise Italy 11 93 0.4× 205 0.9× 5 0.1× 3 0.0× 138 2.1× 27 369
Nadir Ali Pakistan 9 12 0.1× 25 0.1× 35 0.4× 62 0.9× 78 1.2× 56 307
Robin Dewar United States 4 25 0.1× 249 1.1× 15 0.2× 6 0.1× 302 4.6× 4 725
Peter Ott Switzerland 11 14 0.1× 76 0.3× 9 0.1× 48 0.7× 216 3.3× 14 421
S.F.A. Patruno Italy 9 209 0.9× 192 0.9× 13 0.2× 3 0.0× 72 1.1× 23 308

Countries citing papers authored by Michel Branger

Since Specialization
Citations

This map shows the geographic impact of Michel Branger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Branger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Branger more than expected).

Fields of papers citing papers by Michel Branger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Branger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Branger. The network helps show where Michel Branger may publish in the future.

Co-authorship network of co-authors of Michel Branger

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Branger. A scholar is included among the top collaborators of Michel Branger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Branger. Michel Branger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thibault, Vincent, Catherine Gaudy‐Graffin, Philippe Colson, et al.. (2013). Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study. Virology Journal. 10(1). 87–87. 9 indexed citations
2.
3.
Fallot, Guillaume, Boris Halgand, Michel Branger, et al.. (2011). Recombination of hepatitis B virus DNA in patients with HIV. Gut. 61(8). 1197–1208. 6 indexed citations
4.
Ouwe‐Missi‐Oukem‐Boyer, Odile, Benjamin Ollomo, Maria Makuwa, et al.. (2011). Hepatitis C Virus Infection May Lead to Slower Emergence of P. falciparum in Blood. PLoS ONE. 6(1). e16034–e16034. 9 indexed citations
5.
Lada, Olivier, Anne Gervais, Michel Branger, et al.. (2011). Quasispecies Analysis and In Vitro Susceptibility of HBV Strains Isolated from HIV–HBV-Coinfected Patients with Delayed Response to Tenofovir. Antiviral Therapy. 17(1). 61–70. 13 indexed citations
6.
Lada, Olivier, Anne Gervais, Michel Branger, et al.. (2011). Long‐term outcome of primary non‐responders to tenofovir therapy in HIV/HBV‐co‐infected patients: impact of HBV genotype G. Liver International. 32(1). 93–101. 15 indexed citations
7.
Makuwa, Maria, Richard Njouom, Michel Branger, et al.. (2008). Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa. BMC Infectious Diseases. 8(1). 82–82. 27 indexed citations
8.
Deuffic‐Burban, Sylvie, D. Abiteboul, Florence Lot, et al.. (2008). Costs and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infection. Gut. 58(1). 105–110. 14 indexed citations
9.
Makuwa, Maria, Odile Ouwe‐Missi‐Oukem‐Boyer, Oliver G. Pybus, et al.. (2008). High prevalence of hepatitis C virus infection and predominance of genotype 4 in rural gabon. Journal of Medical Virology. 80(9). 1581–1587. 27 indexed citations
10.
Lada, Olivier, A. Gervais, Michel Branger, et al.. (2008). 695 LOW RATE OF DELAYED RESPONSE IN LAMIVUDINE EXPERIENCED HIV/HBV CO-INFECTED PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF). Journal of Hepatology. 48. S259–S259. 1 indexed citations
11.
Sifer, C., Jean‐Louis Bénifla, Michel Branger, et al.. (2002). Effects of hepatitis C virus on the apoptosis percentage of granulosa cells in vivo in women undergoing IVF: preliminary results. Human Reproduction. 17(7). 1773–1776. 14 indexed citations
12.
Buffet‐Janvresse, Claudine, H. Peigue‐Lafeuille, Jacques Bénichou, et al.. (2002). HIV and HCV co‐infection: Situation at six French university hospitals in the year 2000. Journal of Medical Virology. 69(1). 7–17. 10 indexed citations
13.
Korobelnik, Jean‐François, et al.. (1996). Autologous Platelet Concentrate as an Adjunct in Macular Hole Healing. Ophthalmology. 103(4). 590–594. 80 indexed citations
14.
Gournay, Jérôme, Patrick Marcellin, Michèle Martinot‐Peignoux, et al.. (1995). Hepatitis C virus genotypes in French blood donors. Journal of Medical Virology. 45(4). 399–404. 19 indexed citations
15.
Marcellin, Patrick, et al.. (1994). Hepatitis C Virus (HCV) Viremia in Human Immunodeficiency VirusSeronegative and -Seropositive Patients with Indeterminate HCV Recombinant Immunoblot Assay. The Journal of Infectious Diseases. 170(2). 433–435. 54 indexed citations
16.
Martinot‐Peignoux, Michèle, Patrick Marcellin, Jérôme Gournay, et al.. (1994). Detection and quantitation of serum HCV-RNA by branched DNA amplification in anti-HCV positive blood donors. Journal of Hepatology. 20(5). 676–678. 27 indexed citations
17.
Marcellin, Patrick, Michèle Martinot‐Peignoux, Michel Branger, et al.. (1993). Chronic non-B, non-C hepatitis among blood donors assessed with HCV third generation tests and polymerase chain reaction. Journal of Hepatology. 19(1). 167–170. 22 indexed citations
18.
Branger, Michel, et al.. (1992). Collecte de plasma hyperimmun anti-HBs : stimulation par Genhevac B chez les donneurs faiblement immunisés. PubMed. 35(5). 325–334. 1 indexed citations
19.
Mf, Kahn, et al.. (1985). [Controlled prospective study of clinical and biological thyroid parameters in rheumatoid polyarthritis].. PubMed. 52(5). 317–21. 3 indexed citations
20.
Bertrand, S., et al.. (1979). Use of G banding technique in the cytogenetic study of metastatic breast cancer effusion. A case report. European Journal of Cancer (1965). 15(5). 737–743. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrzej Gładysz Breakdown of academic impact, for papers by Charles H. Sherwood Breakdown of academic impact, for papers by Jin Cao Breakdown of academic impact, for papers by Jennifer Hoffmann Breakdown of academic impact, for papers by Corklin Steinhart Breakdown of academic impact, for papers by Enzo Raise Breakdown of academic impact, for papers by Nadir Ali Breakdown of academic impact, for papers by Robin Dewar Breakdown of academic impact, for papers by Peter Ott Breakdown of academic impact, for papers by S.F.A. Patruno
Rankless by CCL
2026